ArticleMicrobial cell factories2026
Candolleomyces candolleanus P9 from Altay Glycyrrhiza: β-glucosidase-mediated biotransformation.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Endophytic fungi establish a symbiotic relationship with their host plants, actively engaging in the hosts' physiological and metabolic processes. They can directly or indirectly transform plant metabolites, thereby playing a crucial role in the host's overall health and functioning. In this study, we isolated and identified an endophytic fungus, Candolleomyces candolleanus P9 strain, which produces β-glucosidase from Ural Glycyrrhizae Radix in Altay, Xinjiang Uygur Autonomous Region, China. In addition, the enzyme production conditions of strain P9 were optimized using a wheat bran concentration of 30.6 g/L, beef extract concentration of 11.2 g/L, inoculum size of 2.6%, pH 7.23, at 30 °C, with shaking at 150 rpm, and a fermentation duration of 6 days. Under these conditions, the β-glucosidase activity of strain P9 increased by 13.6-fold compared to the initial level. On this basis, the efficiency of converting diurea-based urea into diurea-based elements was further optimized. The optimized results were as follows: conversion time 12 h, temperature 37℃, liquiritin concentration 0.8 mg/mL, pH value 7.5, and the conversion rate reached 93.09%. In addition, the antibacterial and antioxidant effects of the fermentation broth of the P9 strain after biotransformation were significantly better than those of commercial β-glucosidase and control group. In summary, fermentation with the β-glucosidase-producing Candolleomyces candolleanus P9 strain is a potential method for converting liquiritin into liquiritigenin of Glycyrrhiza uralensis Fisch.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.